Mini-mesohepatectomy for tumours at the hepatocaval confluence: A cases series and review of the literature.
Loading...
Embargo End Date
ICR Authors
Authors
Patel, PH
Mavroeidis, V
Doyle, J
Kumar, S
Bhogal, RH
Mavroeidis, V
Doyle, J
Kumar, S
Bhogal, RH
Document Type
Journal Article
Date
2022-06-30
Date Accepted
2022-06-25
Abstract
Liver lesions located adjacent to the middle hepatic vein (MHV) at the hepatocaval confluence are rare. Mini-mesohepatectomy (MMH) allows resection of these lesions with preservation of liver parenchymal volume thus reducing the risk of post-hepatectomy liver failure (PHLF). We evaluated our experience of MMH at our institution and assessed post-operative complications, disease free survival (DFS) and overall survival (OS). All patients undergoing MMH at our institution were included in the study. Intra-operative parameters, histopathological data, DFS and OS were evaluated. 11 patients with colorectal liver metastasis underwent MMH between Jan 2012 and Dec 2020. MMH resulted in R0 resection rate in all patients with no PHLF. There were 1 post-operative bile leaks but no mortality following MMH. Median DFS was 13.5 months with OS being 60 months. MMH offers safe oncological resection of lesions at the MHV at the hepatocaval confluence and should be considered in patients presenting with such lesions.
Citation
International Journal of Surgery Case Reports, 2022, 96 pp. 107363 -
Source Title
International Journal of Surgery Case Reports
Publisher
ELSEVIER SCI LTD
ISSN
2210-2612
eISSN
2210-2612
2210-2612
2210-2612
Collections
Research Team
Gastrointestinal Unit